NIM
CTSO icon

NXG Investment Management’s Cytosorbents Corp CTSO Stock Holding History

NXG Investment Management’s Portfolio CTSO Stock Details CTSO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		– Sell
-11,464
Closed -$25K – 78
2022
Q2 		$25K Sell
11,464
-45,090
-80% -$104K ﹤0.01% 91
2022
Q1 		$180K Buy
56,554
+37,883
+203% +$136K 0.02% 93
2021
Q4 		$78K Sell
18,671
-102,208
-85% -$573K 0.01% 105
2021
Q3 		$982K Buy
120,879
+1,698
+1% +$13.8K 0.1% 75
2021
Q2 		$900K Sell
119,181
-1,114
-0.9% -$9.39K 0.09% 86
2021
Q1 		$1.04M Buy
120,295
+24,847
+26% +$237K 0.12% 77
2020
Q4 		$761K Buy
95,448
+34,435
+56% +$288K 0.08% 99
2020
Q3 		$487K Buy
61,013
+42,798
+235% +$386K 0.07% 83
2020
Q2 		$180K Buy
18,215
+8,199
+82% +$75.3K 0.02% 126
2020
Q1 		$77K Sell
10,016
-7,348
-42% -$37.1K 0.01% 108
2019
Q4 		$67K Sell
17,364
-53,479
-75% -$233K ﹤0.01% 133
2019
Q3 		$356K Buy
+70,843
New +$412K 0.02% 101

Other funds holding CTSO

SC
Skylands Capital Milwaukee, Wisconsin $763M AUM 26.49% 1-Year Est. Return
AC
Avenir Corporation Alexandria, Virginia $820M AUM 2.4% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
GIM
Granahan Investment Management Waltham, Massachusetts $2.07B AUM 56.45% 1-Year Est. Return
SIG
Sargent Investment Group Bethesda, Maryland $759M AUM 28.58% 1-Year Est. Return
Neuberger Berman Group
Neuberger Berman Group New York $131B AUM 28.36% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
CM
CM Management Gulf Breeze, Florida $120M AUM 37.12% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return

NXG Investment Management's CTSO Position: Q3 2022 in Review

NXG Investment Management sold out of Cytosorbents Corp (CTSO) in Q3 2022, closing a stake of 11,464 shares — an estimated $25K sold.

NXG Investment Management first reported a position in CTSO in Q3 2019 and held it in 12 quarters. The position peaked at $1.04M in Q1 2021. 60 funds tracked by Wall St. Rank hold CTSO as of Q3 2022.

  • NXG Investment Management reported no remaining Cytosorbents Corp position as of Q3 2022 after selling out during the quarter.
  • NXG Investment Management sold 11,464 Cytosorbents Corp shares in Q3 2022, an estimated $25K.
  • NXG Investment Management first reported a position in Cytosorbents Corp in Q3 2019 and held it in 12 quarters.
  • NXG Investment Management's Cytosorbents Corp position peaked at $1.04M in Q1 2021.
  • 60 funds tracked by Wall St. Rank held Cytosorbents Corp as of Q3 2022.

Based on NXG Investment Management's 13F filing for Q3 2022, filed 14 Nov 2022.